Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 6 studies | 39% ± 19% | |
| amacrine cell | 3 studies | 34% ± 7% | |
| GABAergic neuron | 3 studies | 44% ± 12% | |
| interneuron | 3 studies | 31% ± 14% | |
| neuron | 3 studies | 23% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 31% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 4487.89 | 653 / 653 | 100% | 42.15 | 605 / 605 |
| brain | 100% | 11524.79 | 2639 / 2642 | 100% | 71.65 | 705 / 705 |
| prostate | 100% | 4811.73 | 245 / 245 | 99% | 29.70 | 499 / 502 |
| kidney | 100% | 3833.58 | 89 / 89 | 99% | 28.51 | 895 / 901 |
| ovary | 99% | 2335.89 | 178 / 180 | 99% | 23.15 | 426 / 430 |
| adrenal gland | 99% | 2940.17 | 256 / 258 | 99% | 37.71 | 227 / 230 |
| pancreas | 99% | 2047.60 | 325 / 328 | 96% | 19.47 | 171 / 178 |
| skin | 96% | 2710.32 | 1736 / 1809 | 99% | 30.61 | 465 / 472 |
| uterus | 96% | 2440.40 | 163 / 170 | 96% | 20.43 | 441 / 459 |
| bladder | 100% | 2117.90 | 21 / 21 | 91% | 17.17 | 461 / 504 |
| lung | 97% | 1896.33 | 559 / 578 | 93% | 17.23 | 1074 / 1155 |
| liver | 88% | 1639.36 | 198 / 226 | 96% | 20.61 | 388 / 406 |
| breast | 87% | 2420.69 | 400 / 459 | 96% | 19.93 | 1069 / 1118 |
| esophagus | 97% | 2180.70 | 1400 / 1445 | 83% | 11.34 | 152 / 183 |
| stomach | 98% | 1982.09 | 352 / 359 | 79% | 11.56 | 225 / 286 |
| intestine | 87% | 1861.53 | 839 / 966 | 76% | 10.93 | 402 / 527 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 32.21 | 29 / 29 |
| spleen | 100% | 3293.92 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 27.08 | 1 / 1 |
| eye | 0% | 0 | 0 / 0 | 99% | 28.28 | 79 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 15.88 | 41 / 45 |
| heart | 84% | 1506.16 | 721 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 81% | 1498.23 | 1078 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 74% | 1178.85 | 889 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 59% | 1043.44 | 545 / 929 | 0% | 0 | 0 / 0 |
| muscle | 9% | 92.52 | 70 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0031146 | Biological process | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
| GO_0036503 | Biological process | ERAD pathway |
| GO_0006516 | Biological process | glycoprotein catabolic process |
| GO_0010498 | Biological process | proteasomal protein catabolic process |
| GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FBXO44 |
| Protein name | F-box only protein 44 (F-box protein FBX30) (F-box/G-domain protein 3) F-box protein 44 |
| Synonyms | FBX30 FBX6A FBG3 FBXO6A FBX44 |
| Description | FUNCTION: Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. |
| Accessions | A0A0A0MSI6 ENST00000376770.5 [Q9H4M3-1] R4GMZ8 ENST00000251546.8 [Q9H4M3-2] ENST00000376762.8 [Q9H4M3-2] B7Z1P2 ENST00000475435.5 ENST00000425796.5 ENST00000376768.5 ENST00000376760.5 [Q9H4M3-2] R4GNH4 ENST00000251547.10 [Q9H4M3-1] ENST00000471895.1 Q9H4M3 |
